- Home
- TIGR vs HROW Comparison
TIGR vs HROW Comparison
Compare TIGR & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TIGR | HROW |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | TIGR | HROW |
|---|---|---|
| Price | $8.75 | $44.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $14.20 | ★ $68.86 |
| AVG Volume (30 Days) | ★ 4.4M | 581.9K |
| Earning Date | 03-17-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 328.15 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $489,538,356.00 | $250,042,000.00 |
| Revenue This Year | $79.26 | $38.96 |
| Revenue Next Year | $5.17 | $43.38 |
| P/E Ratio | $10.61 | ★ N/A |
| Revenue Growth | ★ 76.50 | 47.83 |
| 52 Week Low | $6.38 | $20.85 |
| 52 Week High | $13.55 | $54.85 |
Technical Indicators
Market Signals| Indicator | TIGR | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 40.33 |
| Support Level | $8.53 | $44.55 |
| Resistance Level | $9.38 | $47.86 |
| Average True Range (ATR) | 0.59 | 2.84 |
| MACD | -0.14 | -0.80 |
| Stochastic Oscillator | 7.61 | 5.95 |
Price Performance
Historical ComparisonAbout TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.